a randomized , double-blind study was done to compare the efficacy and toxicity of daily single-dose therapy with intravenous ceftriaxone ( 2 g every 24 h ) with daily multiple-dose therapy with cefotaxime ( 2 g every 6 h ) for treatment of serious bacterial infections in nonneutropenic patients .
C0007561
ceftriaxone
C0007554
cefotaxime